The estimated Net Worth of Paul R Gudonis is at least $4.02 Milión dollars as of 30 August 2023. Mr Gudonis owns over 48,400 units of Myomo Inc stock worth over $3,583,240 and over the last 20 years he sold MYO stock worth over $0. In addition, he makes $439,710 as Chairman a Pres & CEO at Myomo Inc.
Mr has made over 7 trades of the Myomo Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he bought 48,400 units of MYO stock worth $35,816 on 30 August 2023.
The largest trade he's ever made was buying 307,692 units of Myomo Inc stock on 17 January 2023 worth over $101,538. On average, Mr trades about 18,858 units every 56 days since 2004. As of 30 August 2023 he still owns at least 878,245 units of Myomo Inc stock.
You can see the complete history of Mr Gudonis stock trades at the bottom of the page.
Paul R. Gudonis is the Chairman, Pres & CEO at Myomo Inc.
As the Chairman a Pres & CEO of Myomo Inc, the total compensation of Mr Gudonis at Myomo Inc is $439,710. There are no executives at Myomo Inc getting paid more.
Mr Gudonis is 66, he's been the Chairman a Pres & CEO of Myomo Inc since . There are 1 older and 6 younger executives at Myomo Inc. The oldest executive at Myomo Inc is Clifford J. Conneighton, 71, who is the Chief Marketing Officer.
Paul's mailing address filed with the SEC is C/O MYOMO, INC., 137 PORTLAND ST., 4TH FLOOR, BOSTON, MA, 02114.
Over the last 7 years, insiders at Myomo Inc have traded over $203,224 worth of Myomo Inc stock and bought 776,898 units worth $937,925 . The most active insiders traders include Steve Sanghi, Paul R Gudonis a Heather C Getz. On average, Myomo Inc executives and independent directors trade stock every 57 days with the average trade being worth of $120,686. The most recent stock trade was executed by Harry Kovelman on 5 September 2024, trading 6,700 units of MYO stock currently worth $25,192.
myomo's mission is to enable individuals to overcome their paralysis by providing innovative, myoelectric orthotics and support services. we are committed to working with healthcare professionals to deliver high quality outcomes and patient satisfaction through research collaborations and continuing education programs. the company empowers persons with a neuromuscular disability to perform functional activities at home, at work, and in the community, resulting in an improved quality of life and lower healthcare costs.
Myomo Inc executives and other stock owners filed with the SEC include: